Motif Bio gearing up to present at major conference on infectious diseases
Graham Lumsden, chief executive of Motif Bio Plc (LON:MTFB), tells Proactive they've got a busy week lined up in early October, when they'll be presenting at the annual Infectious Diseases conference.
The clinical stage biopharmaceutical company specialising in developing novel antibiotics, announced that three abstracts have been accepted for poster presentations at the Infectious Diseases Week Annual Meeting in San Diego 4-8 October 2017.
''Infectious Diseases week is a major conference. About 6,000 healthcare professionals usually attend so it's a good place for us to have a presence and continue to build awareness and knowledge around iclaprim'', Lumsden says.